Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative
Vishnu Kumarasamy(Roswell Park Comprehensive Cancer Center), Daekyu Sun(University of Arizona)
Cited by 15
Related Papers
Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents
|Nucleic Acids Research|2005|403
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
|Science|2019|238
The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer
|Cancer Research|2024|45
Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine
|BMC Cancer|2015|36
Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle
|Nature Communications|2025|28